Search
Biomea Fusion Inc
BMEAAdd to Watchlist
1.250USD
-0.010-0.79%
Close 07-28 16:00（ET）Quotes delayed by 15 min
90.37MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
7
analysts
Buy
Current Rating
7.400
Target Price
+492.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Biomea Fusion Inc
BMEA
7
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Biomea Fusion Inc's price target?
Analysts forecast that Biomea Fusion Inc's price target is USD 6.50, with the highest forecast at USD 16.00 and the lowest forecast at USD 4.00.
How have Biomea Fusion IncBMEA's recent earnings per share performed?
The market expectation was USD -0.17, while Biomea Fusion IncBMEA's earnings per share (EPS) for the previous quarter was USD 0.06. EPS for the next quarter is expected at USD -0.22.
What is the analyst rating for Biomea Fusion Inc?
Based on the ratings of Biomea Fusion Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.